Research Papers:

Long noncoding RNAs as auxiliary biomarkers for gastric cancer screening: A pooled analysis of individual studies

Zhaolei Cui, Yan Chen _, Zhenzhou Xiao, Minhua Hu, Yingying Lin, Yansong Chen and Yuhong Zheng

PDF  |  HTML  |  How to cite

Oncotarget. 2016; 7:25791-25800. https://doi.org/10.18632/oncotarget.8268

Metrics: PDF 2221 views  |   HTML 2530 views  |   ?  


Zhaolei Cui1, Yan Chen1, Zhenzhou Xiao1, Minhua Hu1, Yingying Lin1, Yansong Chen1, Yuhong Zheng1

1Department of Clinical Laboratory, Fujian Provincial Key Laboratory of Tumor Biotherapy, Fujian Provincial Cancer Hospital, Teaching Hospital of Fujian Medical University, Fuzhou, Fujian, China

Correspondence to:

Yan Chen, e-mail: [email protected]

Keywords: lncRNA, gastric cancer, biomarker, diagnostic accuracy, meta-analysis

Received: November 09, 2015     Accepted: March 10, 2016     Published: March 22, 2016


Background: Long non-coding RNAs (lncRNAs) are highlighted as novel cancer biomarkers with great promise. Herein, we focused on summarizing the overall diagnostic performance of lncRNAs for gastric cancer (GC).

Methods: Publications fulfilling the search criteria were selected from the online databases. Study quality was assessed according to the Quality Assessment for Studies of Diagnostic Accuracy (QUADAS) checklist. The summary receiver operator characteristic (SROC) curve was plotted using a bivariate meta-analysis model. Statistical analysis was performed based on the platforms of STATA 12.0 and Meta-Disc 1.4 software.

Results: Fifteen studies with 1252 patients and 1283 matched controls were included. The pooled sensitivity and specificity for lncRNA expression profile in differentiating GC patients from cancer-free individuals were 0.68 (95%CI: 0.61-0.74) and 0.79 (95%CI: 0.72-0.84), respectively, corresponding to an area under curve (AUC) of 0.80. Moreover, the stratified analyses demonstrated that plasma-based lncRNA profiling harbored higher accuracy than that tissue-based assay (specificity: 0.80 versus 0.75; AUC: 0.84 versus 0.77).

Conclusions: LncRNA profiling hallmarks a moderate diagnostic value in the management of GC and that lncRNA expression patterns may potentially be utilized as auxiliary biomarkers in confirming GC.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8268